Research
Business Services · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6440 N Swan Rd Ste 200, Tucson, Arizona,...Phone Number
(520) 748-4413Website
www.clearcoli.comRevenue
$10.2 MillionIndustry
About Research
Research Org Chart
Is Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Research has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Research launches new products
Check out if Research is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Research
Click to see if Research had a recent Job posting/layoffs
Earning: See what the market has to say on Research recently announced quarterly report
Funding: Get notified immidiatlly once Research has new funding data
Research, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Research
Find more new buyers
Company Profile Activity
Activity Insights
Research is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Research.
Research Tech Stack
A closer look at the technologies used by Research
Research News & Media
C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation
The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 /PRNewswire/ -- Critical Path Institute (C-Path) today announced it has been awarded a grant from the Frederick Gardner Cottrell Foundation, a non-profit organization...RCT Acquires Translational Drug Development, LLC
TUCSON, Ariz. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization. TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovatiHalo Labs Raises $5.6M in Series B Financing Round
SAN FRANCISCO, Dec. 20, 2018 /PRNewswire/ -- Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has closed a $5.6M Series B financing round led by Research Corporation Technologies (RCT). The funding will be used to support the ...
Top Business Services Companies
Frequently Asked Questions Regarding Research
Research Corporation Technologies develops ClearColi expression technology, a genetically modified E. coli strain designed for virtually endotoxin-free protein and DNA production. The technology disables the endotoxin signal typically found in lipopolysaccharides while maintaining protein expression capability and competency, which simplifies purif... Read More